Efficacy, safety feasibility of 5-azacitidine for the treatment of myelodysplastic syndromes in the clinical practice: final results from a retrospective study in177 patients enrolled in the italian patient named program / MUSTO, P; MAURILLO, L; SPAGNOLI, A; VILLANI, O; GOZZINI, A; CECCONI, N; D'ARGENIO, M; LUNGHI, M; PALUMBO, G; RIVELLINI, F; GENUARDI, M; SIBILAA, S; MELE, G; FILARDI, N; SAMPAOLO, G; VIGNA, E; PASTORE, D; TONSO, A; FILI, C; CANDONI, A; POLLIO, F; ROCCO, S; SANTAGOSTINO, A; BALLEARI, E; CASSIBA, V; DELLA CIOPAA, P; MAZZONE, C; MIANULLI, M; OLIVA, E; CIUFFREDA, L; ORCIUOLO, E; TATARELLI, C; RUSSO, D; DI RENZO, N; D'ARCO A., M; METTIVIER, V; MORABITO, F; CASCAVILLA, N; MAZZA, P; DI RAIMONDO, FRANCESCO; ALOE SPIRITI M., A; GAIDANO, G; FERRERO, D; QUARTA, G; RIEZZO, A; PAVONE, V; SPECCHIA, G; LEVIS, A; PETRINI, M; OLIVIERI, A; FERRARA, F; VOSO M., T; LEONE, G; VENDITTI, A; SANTINI, V.. - 94(2009), pp. 32-32.
Titolo: | Efficacy, safety feasibility of 5-azacitidine for the treatment of myelodysplastic syndromes in the clinical practice: final results from a retrospective study in177 patients enrolled in the italian patient named program |
Autori interni: | |
Data di pubblicazione: | 2009 |
Handle: | http://hdl.handle.net/20.500.11769/82197 |
Appare nelle tipologie: | 4.1 Contributo in Atti di convegno |